SDS Life Science AB får ett nytt utseende och byter logga till Cytel

SDS Life Science AB, en i Sverige framstående aktör inom biostatistik, klinisk farmakologi, toxikologi, CMC, regulatoriska strategier och klinisk projektledning...

Positive trend for Swedish medtech exports – “We have new markets that are huge”

In 2024, Swedish exports of pharmaceuticals decreased for the first time in several years. However, the trend for medical technology looks brighter. During a se...

She is CSL Behring's new Nordic General Manager

Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.

Eternal Rye – Improving Plant Breeding Methods

User story from Martin Luther University Halle.

Merck KGaA acquires American company in €3.0 billion deal

Germany’s Merck is completing the acquisition of Springwork Therapeutics for 3 billion euros.

LINK Medical recruits Swedish CEO

The Norwegian Contract Research Organization LINK Medical has recruited Anders Göransson as the new CEO.

The pandemic caused a reshuffle among the world’s vaccine giants – here is the new top list

Fuelled by the pandemic, the power balance in the global vaccine market has completely changed in recent years, a survey from Fierce Pharma shows

Getinge köper amerikanskt bolag – ska ”omdefiniera marknadsstandarden”

Getinge har ingått ett avtal om att förvärva det amerikanska företaget Paragonix Technologies. Köpet ska positionera Getinge inom transplantationsområdet.

Hon är ny på Gradientech

Diagnostikbolaget Gradientech har rekryterat AnnaLotta Schiller Vestergren till tjänsten som Chief Commercial Officer.

Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

ZEISS är redo för Elmia Verktygsmaskiner

Du kan få en demonstration av mätmaskinen ZEISS CONTURA.

Grönt ljus för Kennedy sänker läkemedelsbolag

Flera läkemedelsbolag backar på börsen efter att senatskommittén godkänt Robert F. Kennedy Jr som kandidat till landets hälsominister.

Teresia Lönn är ny affärsområdeschef på Medhouse

Nyheter från Medhouse

List: The coolest names in biotech

Hairy beasts, volcanic material and space strolling stand out on a US list of the best biotech company names, and on a list of the coolest names for pharmaceuti...

“We should avoid surgery if we can”

Since February this year, she has been Scientific Director Life Science at the Karolinska Institutet. Life Science Sweden met Anna Martling for a talk about rol...

Health politician Lina Nordquist: ”I find it hard to be idle”

She is the pharmacist and researcher who grew tired of the breakthroughs that never materialised and knowledge that never seemed to reach patients, so she decid...

Karriärcoachen: Så får du arbetsmarknadens mest eftertraktade egenskap

”Hur ska man kunna hänga med?”. Det är en fråga många ställer sig när den tekniska utvecklingen nu rusar fram. Men, enligt karriärcoachen Tina Persson ska du fo...

Icelandic pharmaceutical company Alvotech to list on Nasdaq Stockholm

One of Iceland's largest companies, the pharmaceutical firm Alvotech, has announced its intention to list on Nasdaq Stockholm.

Industrifonden värvar Fredrik Lehman till sitt life science-team

Fredrik Lehman blir ny Venture Partner på Industrifonden med inriktning på life science.

Multiplex immunofluorescence chemistries with ZEISS tissue multiplexing workflow

Bringing leading multiplex immunofluorescence chemistries together in one automated 8-channel imaging platform.

ZEISS Smartzoom 100 for Inspection Efficiency

Catch up on our free webinar.

Mercodia AB

Pfizer värvar FDA-topp – kritiseras hårt

Läkemedelsjätten Pfizers rekrytering av Patrizia Cavazzoni, tills helt nyligen toppchef vid FDA, som ny medicinsk chef får frän kritik från flera håll.

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.